StonvexLoading…
StonvexCore line items from LXFR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $92.11M | $83.90M | $384.60M | $293.90M | $201.00M |
Operating Income | Not available | $6.20M | $24.00M | $20.70M | $15.30M |
Net Income | Not available | $3.60M | $7.70M | $10.80M | $2.60M |
EPS (Diluted) | $0.30 | $0.13 | $0.28 | $0.40 | $0.30 |
Total Assets | Not available | $392.40M | $369.70M | $377.40M | $399.20M |
Total Liabilities | Not available | $168.90M | $143.30M | $145.80M | $161.50M |
Cash & Equivalents | Not available | $14.80M | $8.30M | $6.00M | $4.40M |
Free Cash Flow OCF − CapEx | Not available | $-6.10M | $26.20M | $13.80M | $3.50M |
Shares Outstanding | Not available | 26.75M | 26.64M | 26.72M | 26.76M |